help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 6, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2659
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/5/1834    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gormsen, L. C.
Right arrow Articles by Møller, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gormsen, L. C.
Right arrow Articles by Møller, N.

Submitted on December 1, 2006
Accepted on February 27, 2007

Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans

L. C. Gormsen*, N. Jessen, J. Gjedsted, S. Gjedde, H. Nørrelund, S. Lund, J. S. Christiansen, S. Nielsen, O. Schmitz, and N. Møller

Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital, DK-8000 Aarhus, Denmark, Department of Pharmacology, Aarhus University, DK-8000 Aarhus, Denmark,Department of Anesthesiology, Aarhus University Hospital, DK-8000 Aarhus, Denmark, Immunoendocrine Research Unit, Aarhus University Hospital, DK-8000 Aarhus, Denmark

* To whom correspondence should be addressed. E-mail: lars.christian.gormsen{at}ki.au.dk.

Context: Growth hormone and other stress hormones stimulate lipolysis which may result in free fatty acid (FFA) mediated insulin resistance. However, there are also indications that FFAs in the very low physiological range have the same effect.

Objective: To systematically address dose-response relations between FFAs and insulin sensitivity.

Design: We therefore examined 8 healthy men for 8 h (6 h basal and 2 h glucose clamp) on 4 occasions.

Intervention: Intralipid was infused at varying rates (0, 3, 6, 12 µl/kg/min), lipolysis was blocked by acipimox, and endogenous GH, insulin, and glucagon secretion was blocked by somatostatin and subsequently replaced at fixed rates.

Results: This resulted in four different FFA levels between 50 and 2000 µmol/liter, with comparable levels of insulin and counter regulatory hormones. Both in the basal state and during insulin stimulation, we saw progressively decreased glucose disposal, non-oxidative glucose disposal and forearm muscle glucose uptake at FFA levels above 500 µmol/l. Apart from forearm glucose uptake the very same parameters were decreased at low FFA levels (~50 µmol/liter). FFA rate of disposal was linearly related to the level of FFAs, whereas lipid oxidation reached a max at FFA levels ~1000 µmol/l.

Conclusion: In the presence of comparable levels of all major metabolic hormones, insulin sensitivity peaks at physiological levels of FFAs with a gradual decrease at elevated as well as suppressed FFA concentrations. These data constitute comprehensive dose-response curves for FFAs in the full physiological range from close to zero to above 2000 µmol/l.


Key words: Growth hormone • FFA • intralipid • somatostatin • acipimox • insulin resistance • insulin signaling • cytokines




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
J. de Wilde, R. Mohren, S. van den Berg, M. Boekschoten, K. W.-V. Dijk, P. de Groot, M. Muller, E. Mariman, and E. Smit
Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice
Physiol Genomics, February 19, 2008; 32(3): 360 - 369.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society